Home Blood Pressure Can Predict the Risk for Stroke/Bleeding Events in Elderly Patients With Nonvalvular Atrial Fibrillation From the ANAFIE Registry

Figures

• 

  Figure 1.. Kaplan–Meier curves of net cardiovascular outcome, stroke/systemic embolic events (SEE), major bleeding, intracranial hemorrhage, and all-cause death according to home systolic blood pressure (H-SBP).

• 

  Figure 2.. Incidence rates of clinical outcomes in patients with atrial fibrillation according to home systolic blood pressure (H-SBP). A, Incidence rates of net cardiovascular outcome, stroke/systemic embolic events (SEE), major bleeding, intracranial hemorrhage, and all-cause death according to H-SBP. Bars represent 95% CIs. *P<0.05 versus H-SBP <125 mm Hg. B, Influence of H-SBP on net cardiovascular outcome, stroke/SEE, major bleeding, intracranial hemorrhage, and all-cause death. The Cox proportional hazards model was used, adjusted by sex, age, body mass index, history of major bleeding, atrial fibrillation type, severe hepatic dysfunction, diabetes, hyperuricemia, heart disease (heart failure, left ventricular systolic dysfunction), myocardial infarction, cerebrovascular disease, thromboembolic-related disease, active cancer, dementia, falls within 1 year, anticoagulants, nonpharmacologic therapy (catheter ablation), antiarrhythmics, antiplatelet agents, proton pump inhibitors, P-glycoprotein inhibitors, dyslipidemia, creatinine clearance, gastrointestinal disease, and polypharmacy. Bars represent 95% CIs.

• 

  Figure 3.. Home systolic blood pressure (H-SBP) and incidence rates of clinical outcomes in patients with atrial fibrillation according to number of H-SBP measurements. (A) ≥20 and (B) <20 H-SBP. *P<0.05 versus home systolic blood pressure<125 mm Hg.